FDA warning letter citing over-reliance on AI in CGMP operations (Purolea Cosmetics Lab)

FDA · Final

Last verified: not yet

Unverified: the editor has not yet checked this record against the official source.

Summary

Described as FDA's first CGMP enforcement on AI misuse: the firm used AI to generate specifications and procedures without adequate review. FDA said AI-generated documents must be reviewed for accuracy.

Dated events

1. 2 Apr 2026 Warning letter 320-26-58 issued (2 Apr 2026) Source for Warning letter 320-26-58 issued (2 Apr 2026)

Official source

Official text

Source: FDA. Public domain.